Search Reports
Categories
Categories

Global Canagliflozin Market

Global Canagliflozin Market Research Report 2025(Status and Outlook)

Report Code : PHA3031
Published Date : 17 July, 1905 | No of Pages: 124

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Canagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used primarily to manage type 2 diabetes mellitus by lowering blood glucose levels through increased urinary glucose excretion. It functions by selectively inhibiting SGLT2 in the proximal renal tubules, reducing glucose reabsorption and promoting its elimination via urine. Beyond glycemic control, canagliflozin has demonstrated cardiovascular and renal benefits, including reduced risks of heart failure hospitalization and slowing chronic kidney disease progression, making it a versatile therapeutic option. Marketed under brand names such as Invokana, it competes within the broader SGLT2 inhibitor class alongside drugs like empagliflozin and dapagliflozin. The drug’s adoption is influenced by its efficacy, safety profile, and expanding indications, though concerns like genitourinary infections and rare but serious side effects (e.g., diabetic ketoacidosis) impact prescribing patterns. The global market for canagliflozin is shaped by rising diabetes prevalence, increasing emphasis on cardiovascular risk management in diabetes care, and patent expirations prompting generic competition. Pricing pressures, payer policies, and the uptake of newer therapies also influence its commercial trajectory, with regional variations in accessibility and reimbursement further affecting market dynamics.

This report offers a comprehensive and in-depth analysis of the global Canagliflozin market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Canagliflozin market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Canagliflozin market.
Global Canagliflozin Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Janssen Pharmaceuticals
Mitsubishi Tanabe Pharma
Hansoh Pharma
Hinye

Market Segmentation (by Type)
100mg
300mg

Market Segmentation (by Application)
Diabetes
Heart Disease
Others

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Canagliflozin Market
Overview of the regional outlook of the Canagliflozin Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Canagliflozin Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Canagliflozin, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Canagliflozin
      1.2 Key Market Segments
            1.2.1 Canagliflozin Segment by Type
            1.2.2 Canagliflozin Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Canagliflozin Market Overview
      2.1 Global Market Overview
            2.1.1 Global Canagliflozin Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Canagliflozin Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Canagliflozin Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Canagliflozin Product Life Cycle
      3.3 Global Canagliflozin Sales by Manufacturers (2020-2025)
      3.4 Global Canagliflozin Revenue Market Share by Manufacturers (2020-2025)
      3.5 Canagliflozin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Canagliflozin Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 Canagliflozin Market Competitive Situation and Trends
            3.8.1 Canagliflozin Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Canagliflozin Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Canagliflozin Industry Chain Analysis
      4.1 Canagliflozin Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Canagliflozin Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Canagliflozin Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to Canagliflozin Market
      5.7 ESG Ratings of Leading Companies
  6 Canagliflozin Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Canagliflozin Sales Market Share by Type (2020-2025)
      6.3 Global Canagliflozin Market Size Market Share by Type (2020-2025)
      6.4 Global Canagliflozin Price by Type (2020-2025)
  7 Canagliflozin Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Canagliflozin Market Sales by Application (2020-2025)
      7.3 Global Canagliflozin Market Size (M USD) by Application (2020-2025)
      7.4 Global Canagliflozin Sales Growth Rate by Application (2020-2025)
  8 Canagliflozin Market Sales by Region
      8.1 Global Canagliflozin Sales by Region
            8.1.1 Global Canagliflozin Sales by Region
            8.1.2 Global Canagliflozin Sales Market Share by Region
      8.2 Global Canagliflozin Market Size by Region
            8.2.1 Global Canagliflozin Market Size by Region
            8.2.2 Global Canagliflozin Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Canagliflozin Sales by Country
            8.3.2 North America Canagliflozin Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Canagliflozin Sales by Country
            8.4.2 Europe Canagliflozin Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Canagliflozin Sales by Region
            8.5.2 Asia Pacific Canagliflozin Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Canagliflozin Sales by Country
            8.6.2 South America Canagliflozin Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Canagliflozin Sales by Region
            8.7.2 Middle East and Africa Canagliflozin Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Canagliflozin Market Production by Region
      9.1 Global Production of Canagliflozin by Region(2020-2025)
      9.2 Global Canagliflozin Revenue Market Share by Region (2020-2025)
      9.3 Global Canagliflozin Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Canagliflozin Production
            9.4.1 North America Canagliflozin Production Growth Rate (2020-2025)
            9.4.2 North America Canagliflozin Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Canagliflozin Production
            9.5.1 Europe Canagliflozin Production Growth Rate (2020-2025)
            9.5.2 Europe Canagliflozin Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Canagliflozin Production (2020-2025)
            9.6.1 Japan Canagliflozin Production Growth Rate (2020-2025)
            9.6.2 Japan Canagliflozin Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Canagliflozin Production (2020-2025)
            9.7.1 China Canagliflozin Production Growth Rate (2020-2025)
            9.7.2 China Canagliflozin Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Janssen Pharmaceuticals
            10.1.1 Janssen Pharmaceuticals Basic Information
            10.1.2 Janssen Pharmaceuticals Canagliflozin Product Overview
            10.1.3 Janssen Pharmaceuticals Canagliflozin Product Market Performance
            10.1.4 Janssen Pharmaceuticals Business Overview
            10.1.5 Janssen Pharmaceuticals SWOT Analysis
            10.1.6 Janssen Pharmaceuticals Recent Developments
      10.2 Mitsubishi Tanabe Pharma
            10.2.1 Mitsubishi Tanabe Pharma Basic Information
            10.2.2 Mitsubishi Tanabe Pharma Canagliflozin Product Overview
            10.2.3 Mitsubishi Tanabe Pharma Canagliflozin Product Market Performance
            10.2.4 Mitsubishi Tanabe Pharma Business Overview
            10.2.5 Mitsubishi Tanabe Pharma SWOT Analysis
            10.2.6 Mitsubishi Tanabe Pharma Recent Developments
      10.3 Hansoh Pharma
            10.3.1 Hansoh Pharma Basic Information
            10.3.2 Hansoh Pharma Canagliflozin Product Overview
            10.3.3 Hansoh Pharma Canagliflozin Product Market Performance
            10.3.4 Hansoh Pharma Business Overview
            10.3.5 Hansoh Pharma SWOT Analysis
            10.3.6 Hansoh Pharma Recent Developments
      10.4 Hinye
            10.4.1 Hinye Basic Information
            10.4.2 Hinye Canagliflozin Product Overview
            10.4.3 Hinye Canagliflozin Product Market Performance
            10.4.4 Hinye Business Overview
            10.4.5 Hinye Recent Developments
  11 Canagliflozin Market Forecast by Region
      11.1 Global Canagliflozin Market Size Forecast
      11.2 Global Canagliflozin Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Canagliflozin Market Size Forecast by Country
            11.2.3 Asia Pacific Canagliflozin Market Size Forecast by Region
            11.2.4 South America Canagliflozin Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Canagliflozin by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Canagliflozin Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Canagliflozin by Type (2026-2033)
            12.1.2 Global Canagliflozin Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Canagliflozin by Type (2026-2033)
      12.2 Global Canagliflozin Market Forecast by Application (2026-2033)
            12.2.1 Global Canagliflozin Sales (K MT) Forecast by Application
            12.2.2 Global Canagliflozin Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Janssen Pharmaceuticals
Mitsubishi Tanabe Pharma
Hansoh Pharma
Hinye
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400